The Oncology Institute raises $16.5M via private placement and exchanges $4.1M notes

Oncology Institute, Inc.

Gross proceeds of ~$16.5M from issuing 12.0M common shares, pre-funded warrants for 2.9M shares, and common warrants for 7.4M shares.
Deerfield exchanges ~$4.1M senior secured convertible notes for 37,233 preferred shares (convertible into 3.7M common) and warrants for 1.9M shares.
Common warrants exercisable at $1.1980/share for 5 years; pre-funded warrants at $0.0001/share.
Proceeds to support organic growth and working capital; closing expected March 26, 2025.

item 1.01 item 3.02 item 3.03 item 5.03 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-25-000460
form_type: 8-K
ticker: TOI
cik: 0001799191
company_name: Oncology Institute, Inc.
filed_at: 2025-03-25T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.912064+00:00
generated_at: 2026-05-24T05:56:22.999885+00:00
sec_items: ["1.01", "3.02", "3.03", "5.03", "7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-25-000460
json_url: https://secwatch.observer/filing/0001079973-25-000460.json
markdown_url: https://secwatch.observer/filing/0001079973-25-000460.md
text_url: https://secwatch.observer/filing/0001079973-25-000460.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000460/0001079973-25-000460-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000460/toi_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-25-000460

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.